Cargando…
新局面下对血液肿瘤药物创新研发的思考
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Editorial office of Chinese Journal of Hematology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8770877/ https://www.ncbi.nlm.nih.gov/pubmed/35045665 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2021.12.001 |
_version_ | 1784635466919706624 |
---|---|
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8770877 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Editorial office of Chinese Journal of Hematology |
record_format | MEDLINE/PubMed |
spelling | pubmed-87708772022-02-13 新局面下对血液肿瘤药物创新研发的思考 Zhonghua Xue Ye Xue Za Zhi 专论 Editorial office of Chinese Journal of Hematology 2021-12 /pmc/articles/PMC8770877/ /pubmed/35045665 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2021.12.001 Text en 2021年版权归中华医学会所有 https://creativecommons.org/licenses/by/3.0/This work is licensed under a Creative Commons Attribution 3.0 License. |
spellingShingle | 专论 新局面下对血液肿瘤药物创新研发的思考 |
title | 新局面下对血液肿瘤药物创新研发的思考 |
title_full | 新局面下对血液肿瘤药物创新研发的思考 |
title_fullStr | 新局面下对血液肿瘤药物创新研发的思考 |
title_full_unstemmed | 新局面下对血液肿瘤药物创新研发的思考 |
title_short | 新局面下对血液肿瘤药物创新研发的思考 |
title_sort | 新局面下对血液肿瘤药物创新研发的思考 |
topic | 专论 |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8770877/ https://www.ncbi.nlm.nih.gov/pubmed/35045665 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2021.12.001 |
work_keys_str_mv | AT xīnjúmiànxiàduìxuèyèzhǒngliúyàowùchuàngxīnyánfādesīkǎo AT xīnjúmiànxiàduìxuèyèzhǒngliúyàowùchuàngxīnyánfādesīkǎo AT xīnjúmiànxiàduìxuèyèzhǒngliúyàowùchuàngxīnyánfādesīkǎo AT xīnjúmiànxiàduìxuèyèzhǒngliúyàowùchuàngxīnyánfādesīkǎo AT xīnjúmiànxiàduìxuèyèzhǒngliúyàowùchuàngxīnyánfādesīkǎo AT xīnjúmiànxiàduìxuèyèzhǒngliúyàowùchuàngxīnyánfādesīkǎo |